Loading...
OTCM
MITI
Market cap134mUSD
Jul 31, Last price  
0.04USD
1D
-5.53%
1Q
-44.77%
Jan 2017
-99.62%
Name

Mitra Investindo Tbk PT

Chart & performance

D1W1MN
OTCM:MITI chart
P/E
4,584,186.26
P/S
59,076,064.82
EPS
0.00
Div yield, %
—
Shrs. gr., 5y
65.66%
Rev. gr., 5y
2.75%
Revenues
39k
-11.44%
00000159,359176,437227,65500003,5000115,994690,534043,70038,700
Net income
499k
P
-16,057-8,628-18,112-18,112-21,383-2,428,000-3,402,000-3,770,000-403,014-4,881,000-754,000-1,415,000-3,885,000-2,861,000-7,923,000-23,236,000-13,332,000-2,512,000498,724
CFO
-702k
L+36.39%
-13,994-6,270-17,039-11,050-15,047-1,448,425-2,108,952-1,444,075-366,440-269,508-47,000-246,932-784,469-1,520,862-4,995,946-5,173,840-759,730-514,409-701,585

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Mitesco, Inc., headquartered in Saint Louis Park, Minnesota, oversees a network of healthcare facilities operating under "The Good Clinic" brand. These clinics are primarily situated in North East Minneapolis, United States, providing a diverse array of services. Their offerings encompass wellness guidance, mental health support, acute care, dermatological treatments, and nutritional products. The organization previously operated as True Nature Holding, Inc. before adopting its current name, Mitesco, Inc., in April 2020.
URL
https://www.mitra-investindo.com/
IPO date
Jul 16, 1997
Employees
Domiciled in
ID
Incorporated in
ID

Valuation

Title
IDR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT